Skip to main content

Naproxen

NDC 70954-928 · ANI Pharmaceuticals, Inc.

Generic nameNaproxen
Dosage formTABLET, DELAYED RELEASE
RouteORAL
Active ingredient(s)NAPROXEN
Strength500 mg/1
Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
Marketing categoryANDA

Packages

70954-928-10 — 100 TABLET, DELAYED RELEASE in 1 BOTTLE (70954-928-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70010-137 — Naproxen, 70010-138 — Naproxen, 70010-139 — Naproxen, 70518-1516 — Naproxen, 70518-3486 — Naproxen, 70518-3822 — Naproxen, 70518-4439 — Naproxen, 70518-4514 — Naproxen, 70954-151 — Naproxen oral, 70954-925 — Naproxen, 71205-060 — Naproxen, 71205-597 — Naproxen, 71335-0095 — Naproxen, 71335-0217 — Naproxen, 71335-0255 — NAPROXEN, 71335-0345 — Naproxen, 71335-0973 — NAPROXEN, 71335-1850 — Naproxen, 71335-1869 — Naproxen, 71335-2485 — Naproxen, +171 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels